Matthew Harrison
Stock Analyst at Seaport Global
(3.41)
# 948
Out of 4,641 analysts
746
Total ratings
48.34%
Success rate
3.7%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVNT Avient | Downgrades: Neutral | n/a | $47.87 | - | 1 | Oct 18, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintains: Equal-Weight | $462 → $474 | $470.05 | +0.84% | 35 | Oct 1, 2024 | |
| IOBT IO Biotech | Maintains: Overweight | $4 → $6 | $1.24 | +383.87% | 5 | Sep 16, 2024 | |
| AVIR Atea Pharmaceuticals | Upgrades: Equal-Weight | $2 → $6.88 | $3.48 | +97.70% | 9 | Aug 13, 2024 | |
| TSVT 2seventy bio | Maintains: Equal-Weight | $7 → $6 | $5.06 | +18.58% | 9 | Jul 29, 2024 | |
| INSM Insmed | Maintains: Overweight | $60 → $85 | $71.94 | +18.15% | 15 | Jul 12, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Overweight | $1,183 → $1,182 | $941.39 | +25.56% | 49 | Jul 11, 2024 | |
| SRPT Sarepta Therapeutics | Maintains: Overweight | $165 → $200 | $129.88 | +53.99% | 34 | Jun 24, 2024 | |
| CNTA Centessa Pharmaceuticals | Maintains: Equal-Weight | $8 → $11 | $15.15 | -27.39% | 9 | Jun 21, 2024 | |
| ZNTL Zentalis Pharmaceuticals | Downgrades: Equal-Weight | $38 → $8 | $3.32 | +140.96% | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $510 | $557.92 | -8.59% | 24 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $3.21 | +118.07% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $78 | $87.23 | -10.58% | 37 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $112 | $69.98 | +60.05% | 21 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 | $22.21 | +53.08% | 14 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $22.73 | +40.78% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $361 → $373 | $182.98 | +103.85% | 49 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $321 → $319 | $221.01 | +44.34% | 27 | Aug 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $3.99 | +376.19% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $14 | $1.87 | +648.66% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $10 | $4.67 | +114.13% | 9 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $128 → $123 | $53.39 | +130.38% | 23 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $65 → $85 | $43.95 | +93.40% | 10 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underweight | $3 | $0.51 | +485.14% | 30 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $41.55 | +10.71% | 1 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $61 → $63 | $26.08 | +141.56% | 11 | Apr 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $13 | $3.79 | +243.01% | 4 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $0.99 | +1.19% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $19.82 | -49.55% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $3.25 | +146.15% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $29.98 | +46.76% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $3.79 | +243.01% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $4 | $1.15 | +247.83% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $5 → $3 | $0.65 | +361.61% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $110.98 | +94.63% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $2.98 | +67.79% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $2.85 | +75.44% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $187.88 | -3.13% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $3.54 | +154.24% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $40 | $28.67 | +39.52% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $314.90 | -10.45% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $294.87 | -28.78% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $32 → $27 | $0.76 | +3,443.31% | 7 | Sep 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $28.86 | +80.18% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $165.86 | +4.30% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $61 → $57 | $7.65 | +645.10% | 9 | Mar 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $54.69 | +119.42% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $52.75 | +180.57% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $106.38 | -22.92% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $53.06 | +24.39% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $1.97 | +1,879.70% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $27.36 | +68.13% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $17.21 | +103.37% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $903.25 | -69.55% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $2.29 | +729.69% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $9.74 | +536.55% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $15.54 | +11.00% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $50 | $1.37 | +3,549.64% | 4 | Aug 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $65.17 | +27.36% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $59 → $57 | $16.64 | +242.55% | 4 | Oct 11, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $53.04 | -81.15% | 4 | Sep 10, 2018 |
Avient
Oct 18, 2024
Downgrades: Neutral
Price Target: n/a
Current: $47.87
Upside: -
Vertex Pharmaceuticals
Oct 1, 2024
Maintains: Equal-Weight
Price Target: $462 → $474
Current: $470.05
Upside: +0.84%
IO Biotech
Sep 16, 2024
Maintains: Overweight
Price Target: $4 → $6
Current: $1.24
Upside: +383.87%
Atea Pharmaceuticals
Aug 13, 2024
Upgrades: Equal-Weight
Price Target: $2 → $6.88
Current: $3.48
Upside: +97.70%
2seventy bio
Jul 29, 2024
Maintains: Equal-Weight
Price Target: $7 → $6
Current: $5.06
Upside: +18.58%
Insmed
Jul 12, 2024
Maintains: Overweight
Price Target: $60 → $85
Current: $71.94
Upside: +18.15%
Regeneron Pharmaceuticals
Jul 11, 2024
Maintains: Overweight
Price Target: $1,183 → $1,182
Current: $941.39
Upside: +25.56%
Sarepta Therapeutics
Jun 24, 2024
Maintains: Overweight
Price Target: $165 → $200
Current: $129.88
Upside: +53.99%
Centessa Pharmaceuticals
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $15.15
Upside: -27.39%
Zentalis Pharmaceuticals
Jun 18, 2024
Downgrades: Equal-Weight
Price Target: $38 → $8
Current: $3.32
Upside: +140.96%
May 28, 2024
Maintains: Overweight
Price Target: $515 → $510
Current: $557.92
Upside: -8.59%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $3.21
Upside: +118.07%
Apr 26, 2024
Maintains: Equal-Weight
Price Target: $80 → $78
Current: $87.23
Upside: -10.58%
Apr 26, 2024
Maintains: Overweight
Price Target: $115 → $112
Current: $69.98
Upside: +60.05%
Apr 22, 2024
Maintains: Overweight
Price Target: $34
Current: $22.21
Upside: +53.08%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $22.73
Upside: +40.78%
Nov 10, 2023
Maintains: Overweight
Price Target: $361 → $373
Current: $182.98
Upside: +103.85%
Aug 29, 2023
Maintains: Overweight
Price Target: $321 → $319
Current: $221.01
Upside: +44.34%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $3.99
Upside: +376.19%
Aug 10, 2023
Maintains: Overweight
Price Target: $13 → $14
Current: $1.87
Upside: +648.66%
Aug 7, 2023
Reiterates: Equal-Weight
Price Target: $10
Current: $4.67
Upside: +114.13%
Aug 4, 2023
Maintains: Equal-Weight
Price Target: $128 → $123
Current: $53.39
Upside: +130.38%
Jul 20, 2023
Maintains: Overweight
Price Target: $65 → $85
Current: $43.95
Upside: +93.40%
Jul 11, 2023
Reiterates: Underweight
Price Target: $3
Current: $0.51
Upside: +485.14%
Apr 24, 2023
Reiterates: Buy
Price Target: $46
Current: $41.55
Upside: +10.71%
Apr 12, 2023
Maintains: Overweight
Price Target: $61 → $63
Current: $26.08
Upside: +141.56%
Mar 27, 2023
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $3.79
Upside: +243.01%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $0.99
Upside: +1.19%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $19.82
Upside: -49.55%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $3.25
Upside: +146.15%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $29.98
Upside: +46.76%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $3.79
Upside: +243.01%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $4
Current: $1.15
Upside: +247.83%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $5 → $3
Current: $0.65
Upside: +361.61%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $110.98
Upside: +94.63%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $2.98
Upside: +67.79%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $2.85
Upside: +75.44%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $187.88
Upside: -3.13%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $3.54
Upside: +154.24%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30 → $40
Current: $28.67
Upside: +39.52%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $314.90
Upside: -10.45%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $294.87
Upside: -28.78%
Sep 9, 2022
Maintains: Overweight
Price Target: $32 → $27
Current: $0.76
Upside: +3,443.31%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $28.86
Upside: +80.18%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $165.86
Upside: +4.30%
Mar 10, 2022
Maintains: Equal-Weight
Price Target: $61 → $57
Current: $7.65
Upside: +645.10%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $54.69
Upside: +119.42%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $52.75
Upside: +180.57%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $106.38
Upside: -22.92%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $53.06
Upside: +24.39%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $1.97
Upside: +1,879.70%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $27.36
Upside: +68.13%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $17.21
Upside: +103.37%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $903.25
Upside: -69.55%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $2.29
Upside: +729.69%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $9.74
Upside: +536.55%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $15.54
Upside: +11.00%
Aug 18, 2020
Downgrades: Equal-Weight
Price Target: $50
Current: $1.37
Upside: +3,549.64%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $65.17
Upside: +27.36%
Oct 11, 2018
Maintains: Overweight
Price Target: $59 → $57
Current: $16.64
Upside: +242.55%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $53.04
Upside: -81.15%